Clinical Trials Directory

Trials / Sponsors / OncoSec Medical Incorporated

OncoSec Medical Incorporated

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
UnknownTavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic
Triple Negative Breast Cancer
Phase 22018-10-11
UnknownTavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab
Stage III/IV Melanoma
Phase 22017-10-03
CompletedEvaluation of Pharmacodynamic Effects of IT-pIL12-EP in Patients With TNBC
ER-Negative PR-Negative HER2-Negative Breast Cancer
Phase 12015-09-01
TerminatedTrial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)
Head and Neck Squamous Cell Carcinoma
Phase 22015-05-21
TerminatedPhase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma
Cutaneous T Cell Lymphomas (CTCL), Mycosis Fungoides (MF)
Phase 22012-06-08
CompletedTrial of pIL-12 Electroporation Malignant Melanoma
Melanoma
Phase 22012-02-14
CompletedIL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cance
Merkel Cell Carcinoma
Phase 22012-01-03